DUBLIN, IRELAND--(Marketwired - Jan 29, 2015) - Horizon Pharma plc (
- 17th Annual BIO CEO & Investor Conference
- Presentation Date: Tuesday, February 10, 2015
- Presentation Time: 1:30pm E.T.
- 2015 Leerink Global Healthcare Conference
- Presentation Date: Thursday, February 12, 2015
- Presentation Time: 3:05pm E.T.
The presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.
About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. Horizon's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.